Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when NovoCure Ltd publishes a filing, an earnings call transcript or a press release.

Get NVCR alerts

About Martin Madden

Martin Madden is recorded as Board Member at NovoCure Ltd (NVCR) since January 1, 2017. The newest filing on record that lists Martin Madden as Board Member at NovoCure Ltd (NVCR) is dated April 20, 2026. NovoCure Ltd reported in an 8-K filed June 5, 2026 that Martin Madden was appointed director, effective June 3, 2026. NovoCure Ltd reported in an 8-K filed June 6, 2025 that Martin Madden was appointed director, effective June 4, 2025. NovoCure Ltd reported in an 8-K filed June 10, 2024 that Martin Madden was appointed director, effective June 5, 2024. Equibles holds 4 filed executive changes naming Martin Madden; each is listed under recent activity with its source filing. NovoCure Ltd is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at NovoCure Ltd includes Asaf Danziger (CEO and Board Member), David Hung (CEO and Board Member), Frank Leonard (CEO and Board Member) and 7 others.

“The Company’s shareholders elected Asaf Danziger, William Doyle, Jeryl Hilleman, David Hung, Frank Leonard, Kinyip Gabriel Leung, Martin Madden, Allyson Ocean, Timothy Scannell, Kristin Stafford and William Vernon as directors, effective immediately, with a term expiring at the annual meeting of shareholders in 2027.”
NovoCure Ltd Form 8-K, filed June 5, 2026 · Read the filing
“The Company's shareholders elected Ashley Cordova, Asaf Danziger, William Doyle, Jeryl Hilleman, David Hung, Kinyip Gabriel Leung, Martin Madden, Allyson Ocean, Timothy Scannell, Kristin Stafford and William Vernon as directors, effective immediately, with a term expiring at the annual meeting of shareholders in 2026.”
NovoCure Ltd Form 8-K, filed June 6, 2025 · Read the filing

Affiliation history

  • NovoCure Ltd (NVCR)

    Board Member

    Proxy statement

    Current

    2017-01-01–present

    Last confirmed April 20, 2026

  • NovoCure Ltd (NVCR)

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 20, 2026

Company network

Current role

Medical Devices · Healthcare

Board Member

2017-01-01–present

Leadership on record at NovoCure Ltd

Recent activity